Ji-Young Hwang
Director of Finance/CFO bei EXICURE, INC.
Ursprung des Netzwerks ersten Grades von Ji-Young Hwang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
| Public Company | Auto Parts: OEM | 13 | |
| Public Company | Household/Personal Care | 7 | |
| Public Company | Industrial Machinery | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Ji-Young Hwang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Vans, Inc.
 Vans, Inc. Wholesale DistributorsDistribution Services Vans, Inc. designs, manufactures and distributes footwear and apparel for casual wear and for use in activities such as skateboarding, snowboarding, surfing and bicycle motocross. The company was founded by Paul van Doren, Jim Van Doren, Gordon Lee and Serge Delia in 1966 and is headquartered in Cypress, CA. | Wholesale Distributors | Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Gynesonics, Inc.
 Gynesonics, Inc. Medical SpecialtiesHealth Technology Gynesonics, Inc. provides medical devices for women's health. It offers VizAblate System for the transcervical treatment of symptomatic uterine fibroids under intrauterine ultrasound guidance. The company was founded by Jessica grossman in 2005 and is headquartered in Redwood City, CA. | Medical Specialties | Director/Board Member | |
ZipLine Medical, Inc.
 ZipLine Medical, Inc. Medical SpecialtiesHealth Technology ZipLine Medical, Inc. engages in the development of non-invasive surgical skin closure devices. It offers Zip Surgical,m PreLoc Wound Care, and Zipstitch Consumer platforms. The company was founded by Amir Belson in 2009 and is headquartered in Campbell, CA. | Medical Specialties | Director/Board Member | |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Financial Conglomerates | Corporate Officer/Principal | |
Abingworth LLP
 Abingworth LLP Investment ManagersFinance Abingworth LLP is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. | Investment Managers | Chief Investment Officer | |
| University of Oxford | College/University | Doctorate Degree | |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners LLP (MVM Partners) is a venture capital firm founded in 1997. The firm is headquartered in London, the United Kingdom. | Investment Managers | Private Equity Investor | |
| University of Cambridge | College/University | Doctorate Degree | |
| URBAN LITHIUM INC | Telecommunications Equipment | Director/Board Member Chief Executive Officer | |
| The King's College (New York) | College/University | Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| AIBIT CO., LTD. | Electronic Equipment/Instruments | Chief Executive Officer | |
| DGP CO.,LTD. | Oil Refining/Marketing | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Kent County Memorial Hospital
 Kent County Memorial Hospital Hospital/Nursing ManagementHealth Services Kent County Memorial Hospital provides health care services. It also provides inpatient services including cardiology and extended coronary care, infectious disease, primary care, oncology, orthopedics, obstetrics and gynecology, pediatrics, rehabilitation and surgery. The company was founded in 1951 and is headquartered in Warwick, RI. | Hospital/Nursing Management | Corporate Officer/Principal | |
| INCON CO.,LTD. | Electronics/Appliances | Director/Board Member | |
| Seoul National University | College/University | Graduate Degree | |
| State University of New York at Binghamton | College/University | Undergraduate Degree | |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Sungkyunkwan University | College/University | Undergraduate Degree | |
| EM NETWORKS CORPORATION | Electronic Equipment/Instruments | Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Dassiet Oy
 Dassiet Oy Medical SpecialtiesHealth Technology Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland. | Medical Specialties | Director/Board Member | |
St. Thomas Hospital, Inc.
 St. Thomas Hospital, Inc. Hospital/Nursing ManagementHealth Services St. Thomas Hospital, Inc. operates hospitals. The private company is based in St. Thomas, VI. and has subsidiaries in United States. | Hospital/Nursing Management | Corporate Officer/Principal | |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Founder President | |
| SIGNAL INFORMATION & COMMUNICATION CORP | Information Technology Services | Chief Executive Officer Chief Executive Officer | |
| DAE YU CO., LTD. | Chemicals: Agricultural | President Chief Executive Officer Chairman | |
| NUCANA PLC | Biotechnology | Director/Board Member | |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Director/Board Member | |
| VALNEVA | Biotechnology | Director/Board Member Director/Board Member | |
| The Indiana University School of Medicine | College/University | Doctorate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| NDFOS CO., LTD. | Containers/Packaging | Director/Board Member | |
Glycomine, Inc.
 Glycomine, Inc. BiotechnologyHealth Technology Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member | |
Kineta Viral Hemorrhagic Fever LLC
 Kineta Viral Hemorrhagic Fever LLC BiotechnologyHealth Technology Kineta Viral Hemorrhagic Fever LLC provides biotechnology health care services. The company is headquartered in Seattle, WA. | Biotechnology | Director/Board Member Director/Board Member | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Blossom Story Co., Ltd.
 Blossom Story Co., Ltd. Movies/EntertainmentConsumer Services Blossom Story Co., Ltd. engages in the production of movies and videos. The company was founded on September 23, 2016 and is headquartered in Goyang-si, South Korea. | Movies/Entertainment | Chief Executive Officer Comptroller/Controller/Auditor | |
Blossom Pictures Co., Ltd.
 Blossom Pictures Co., Ltd. Movies/EntertainmentConsumer Services Blossom Pictures Co., Ltd. engages in the production of movies and videos. The company was founded on August 1, 2014 and is headquartered in Seoul, South Korea. | Movies/Entertainment | Chief Executive Officer | |
Claris Ventures Sgr SpA
 Claris Ventures Sgr SpA Investment ManagersFinance Claris Ventures Sgr SpA (Claris Ventures) is a venture capital firm founded in 2019 by Pietro Puglisi and Ciro Spedaliere. The firm is headquartered in Turin, Italy. | Investment Managers | Private Equity Investor | |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Packaged Software | Director/Board Member | |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Stryve Online Ltd.
 Stryve Online Ltd. Miscellaneous Commercial ServicesCommercial Services Stryve Online Ltd. is a British company that offers an applicant tracking system designed to improve the hiring process. The company is based in London, UK. The platform is equipped with various features that aim to make the process more efficient. It was founded in 2019 by Edward Chamberlain. | Miscellaneous Commercial Services | Director/Board Member | |
| KINETA, INC. | Pharmaceuticals: Major | Founder President | |
Launch Therapeutics, Inc.
 Launch Therapeutics, Inc. Financial ConglomeratesFinance Launch Therapeutics, Inc. provides investment and therapies development services. The CEO of the American company is Anshul Thakral. | Financial Conglomerates | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 26 |
| Südkorea | 13 |
| Vereinigtes Königreich | 7 |
| Dänemark | 2 |
| Finnland | 2 |
Sektoral
| Health Technology | 22 |
| Consumer Services | 11 |
| Finance | 6 |
| Electronic Technology | 4 |
| Distribution Services | 3 |
Operativ
| Director/Board Member | 106 |
| Chief Executive Officer | 33 |
| Independent Dir/Board Member | 27 |
| Corporate Officer/Principal | 26 |
| Undergraduate Degree | 17 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Sulat | 23 |
| Michael Hodges | 21 |
| Jeffrey L. Cleland | 21 |
| Bali Muralidhar | 20 |
| Elizabeth Garofalo | 11 |
| Shawn Iadonato | 11 |
| Craig Philips | 10 |
| Rebecca J. Peterson | 9 |
| Matthias G. Schroff | 8 |
| Bong-Doo Seong | 7 |
| Young-Kyu Park | 5 |
| Paul Kang | 4 |
| Woo-Dong Kim | 4 |
| Chul-Han Kim | 3 |
| Elias D. Papadimas | 3 |
- Börse
- Insiders
- Ji-Young Hwang
- Unternehmensverbindungen
